0742 GMT - Siemens is making progress with its stake reduction in its Healthineers subsidiary, but the slow timeline of the spinoff, and uncertainty around macro demand backdrop and AI software risks might still limit investor enthusiasm in the short term, RBC Capital Markets says. The German conglomerate posted in-line second-quarter profitability, with strength in digital industries and smart infrastructure offset by weaker performance in mobility and Healthineers, analysts Mark Fielding and Nick Housden write in a research note. This is slightly disappointing, they add. The company saw orders jump 18% on a comparable basis, ahead of consensus at 8%, and backed its outlook on a group level. Shares trade 2.1% lower at 259.1 euros. (nina.kienle@wsj.com)
(END) Dow Jones Newswires
May 13, 2026 03:44 ET (07:44 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments